Market Closed -
Nyse
04:00:01 2024-05-22 pm EDT
|
5-day change
|
1st Jan Change
|
57.04
USD
|
+2.13%
|
|
-5.22%
|
-23.82%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,911
|
3,210
|
5,783
|
4,456
|
2,830
|
2,167
|
-
|
-
|
Enterprise Value (EV)
1 |
3,445
|
4,043
|
6,445
|
5,235
|
4,033
|
3,146
|
3,024
|
2,987
|
P/E ratio
|
26
x
|
46.1
x
|
18
x
|
10.4
x
|
14
x
|
42.9
x
|
28.3
x
|
17.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.31
x
|
1.34
x
|
1.45
x
|
0.85
x
|
0.75
x
|
0.73
x
|
0.72
x
|
0.69
x
|
EV / Revenue
|
1.55
x
|
1.69
x
|
1.62
x
|
1
x
|
1.06
x
|
1.06
x
|
1.01
x
|
0.95
x
|
EV / EBITDA
|
12.4
x
|
12.6
x
|
10.1
x
|
6.18
x
|
6.96
x
|
9.45
x
|
8.53
x
|
7.96
x
|
EV / FCF
|
18.2
x
|
18.5
x
|
25.6
x
|
9.06
x
|
15
x
|
15.1
x
|
10.2
x
|
8.5
x
|
FCF Yield
|
5.51%
|
5.42%
|
3.91%
|
11%
|
6.66%
|
6.62%
|
9.83%
|
11.8%
|
Price to Book
|
3.95
x
|
3.92
x
|
5.06
x
|
4.13
x
|
3.41
x
|
2.5
x
|
2.4
x
|
2.29
x
|
Nbr of stocks (in thousands)
|
46,711
|
47,031
|
47,275
|
43,336
|
37,789
|
37,997
|
-
|
-
|
Reference price
2 |
62.31
|
68.25
|
122.3
|
102.8
|
74.88
|
57.04
|
57.04
|
57.04
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,222
|
2,394
|
3,984
|
5,243
|
3,789
|
2,981
|
3,006
|
3,143
|
EBITDA
1 |
277.4
|
320.7
|
635.4
|
846.7
|
579.1
|
332.9
|
354.4
|
375.3
|
EBIT
1 |
176.9
|
149.3
|
478
|
647.1
|
338.4
|
133.1
|
184.5
|
339.9
|
Operating Margin
|
7.96%
|
6.24%
|
12%
|
12.34%
|
8.93%
|
4.47%
|
6.14%
|
10.81%
|
Earnings before Tax (EBT)
1 |
148.5
|
91.52
|
443.9
|
606.7
|
284.3
|
58.51
|
97
|
190
|
Net income
1 |
114
|
70.66
|
327.4
|
444
|
210.7
|
50.23
|
86.18
|
208.7
|
Net margin
|
5.13%
|
2.95%
|
8.22%
|
8.47%
|
5.56%
|
1.69%
|
2.87%
|
6.64%
|
EPS
2 |
2.400
|
1.480
|
6.810
|
9.900
|
5.360
|
1.329
|
2.017
|
3.304
|
Free Cash Flow
1 |
189.6
|
219.1
|
251.8
|
577.9
|
268.5
|
208.4
|
297.3
|
351.5
|
FCF margin
|
8.53%
|
9.15%
|
6.32%
|
11.02%
|
7.09%
|
6.99%
|
9.89%
|
11.18%
|
FCF Conversion (EBITDA)
|
68.37%
|
68.33%
|
39.62%
|
68.25%
|
46.36%
|
62.61%
|
83.89%
|
93.64%
|
FCF Conversion (Net income)
|
166.37%
|
310.09%
|
76.91%
|
130.14%
|
127.43%
|
414.95%
|
345.02%
|
168.39%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,363
|
1,553
|
1,427
|
1,139
|
1,126
|
1,126
|
991.3
|
853.5
|
818.3
|
820.9
|
740.4
|
704.1
|
721.1
|
737.4
|
736.8
|
EBITDA
1 |
222.6
|
257.6
|
232.7
|
181.8
|
174.6
|
179.6
|
161.8
|
133.7
|
104
|
97.67
|
83.26
|
73.73
|
78.19
|
84.69
|
86.56
|
EBIT
1 |
168.6
|
207.9
|
183.5
|
136.4
|
119.3
|
125.7
|
91.66
|
86.93
|
34.17
|
39.94
|
25.89
|
23.33
|
26.22
|
34.73
|
35.91
|
Operating Margin
|
12.37%
|
13.39%
|
12.87%
|
11.98%
|
10.6%
|
11.16%
|
9.25%
|
10.19%
|
4.18%
|
4.87%
|
3.5%
|
3.31%
|
3.64%
|
4.71%
|
4.87%
|
Earnings before Tax (EBT)
1 |
158.8
|
198.3
|
173.5
|
127.4
|
107.5
|
115.4
|
79.49
|
75.38
|
14
|
23.32
|
10.59
|
7.782
|
12.37
|
17.88
|
20.71
|
Net income
1 |
116.2
|
146
|
123.8
|
92.44
|
81.8
|
84.11
|
60.91
|
53.17
|
12.49
|
17.33
|
6.317
|
6.773
|
9.923
|
13.33
|
14.66
|
Net margin
|
8.53%
|
9.4%
|
8.68%
|
8.12%
|
7.27%
|
7.47%
|
6.14%
|
6.23%
|
1.53%
|
2.11%
|
0.85%
|
0.96%
|
1.38%
|
1.81%
|
1.99%
|
EPS
2 |
2.420
|
3.090
|
2.770
|
2.100
|
1.880
|
2.020
|
1.550
|
1.390
|
0.3300
|
0.4500
|
0.1707
|
0.1776
|
0.2580
|
0.2883
|
0.3264
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/16/23
|
5/4/23
|
8/3/23
|
11/2/23
|
2/15/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
534
|
833
|
661
|
779
|
1,203
|
979
|
856
|
820
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.926
x
|
2.599
x
|
1.041
x
|
0.92
x
|
2.077
x
|
2.941
x
|
2.416
x
|
2.185
x
|
Free Cash Flow
1 |
190
|
219
|
252
|
578
|
268
|
208
|
297
|
351
|
ROE (net income / shareholders' equity)
|
16.6%
|
9.08%
|
33%
|
40.3%
|
22.5%
|
11.6%
|
13.3%
|
17.3%
|
ROA (Net income/ Total Assets)
|
6.66%
|
3.3%
|
11.9%
|
14.8%
|
7.25%
|
3.4%
|
5.6%
|
6.5%
|
Assets
1 |
1,712
|
2,143
|
2,743
|
3,010
|
2,906
|
1,477
|
1,539
|
3,211
|
Book Value Per Share
2 |
15.80
|
17.40
|
24.20
|
24.90
|
22.00
|
22.80
|
23.80
|
25.00
|
Cash Flow per Share
2 |
4.720
|
5.390
|
6.360
|
14.60
|
9.460
|
6.230
|
6.940
|
9.820
|
Capex
1 |
35.2
|
37.7
|
53.6
|
75.8
|
104
|
61.7
|
64.9
|
65.3
|
Capex / Sales
|
1.58%
|
1.58%
|
1.34%
|
1.45%
|
2.74%
|
2.07%
|
2.16%
|
2.08%
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
57.04
USD Average target price
71.25
USD Spread / Average Target +24.91% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.82% | 2.17B | | +17.63% | 83.4B | | -27.25% | 72.11B | | 0.00% | 27.04B | | -11.48% | 16.96B | | -0.50% | 16.86B | | +2.89% | 15.76B | | +73.23% | 13.33B | | +1.25% | 12.76B | | +72.58% | 12.74B |
Other Healthcare Facilities & Services
|